Ai-biopharma focuses on innovative biopharmaceutical technologies aimed at advancing drug development and improving patient outcomes. The company employs cutting-edge approaches in biotherapeutics, including monoclonal antibodies and gene therapies, to target specific diseases more effectively. Their pipeline showcases a range of products designed to address unmet medical needs, leveraging their expertise in biologics to enhance therapeutic efficacy and safety.

In addition to their product offerings, Ai-biopharma emphasizes the importance of scientific research and development in their operations. They utilize advanced techniques such as high-throughput screening and computational biology to identify and optimize drug candidates. The integration of these technologies allows for a more streamlined development process, ultimately accelerating the delivery of new treatments to patients. Through their commitment to innovation and scientific excellence, Ai-biopharma aims to make significant contributions to the biopharmaceutical landscape.

France

-Artificial Intelligence powered Drug Discovery.
-a Biopharma company specialized in medicinal chemistry research of preclinical drug candidates.
Ai-biopharma has in-silico solutions of Chemoinformatics, Molecular Modeling, Docking, Data analysis, SAR formatting/interpretation and also an Artificial Intelligence platform for the accelerated drug design towards the selection of new preclinical candidate drugs .

Ai-biopharma

Company Details